APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.

IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...

There is growing enthusiasm about China’s potential to speed up drug development with AI. And companies outside the country ...

Arvinas Inc. (NASDAQ:ARVN), a biotechnology company specializing in protein degradation therapeutics, stands at a critical juncture as it approaches the release of pivotal clinical trial data.

New heart health biopharmaceutical company Kardigan, which counts among its co-founders the director for Northwestern ...

In this video, Xiuning Le, MD, PhD, discusses the state of the pipeline for developing EGFR-mutated lung cancer treatments.

Aardvark Therapeutics plans a $100M IPO for metabolic treatments, targeting rare Prader-Willi syndrome with a potential ...

Silence Therapeutics plc (NASDAQ:SLN), a biotechnology company specializing in RNA therapeutics, stands at a crucial juncture ...

Statins help people manage high cholesterol levels, but many experts want to know if these drugs can also support brain ...

Less than two months after an accelerated approval from the FDA, a drug combination featuring Pfizer’s Braftovi has turned in ...

All physicians are faced with the challenge of how to help patients with no approved therapies for their diseases. What are ...